ATE533495T1 - Zusammensetzungen zur behandlung von hautkrankheiten gekennzeichnet durch exsudation von serumproteinen - Google Patents

Zusammensetzungen zur behandlung von hautkrankheiten gekennzeichnet durch exsudation von serumproteinen

Info

Publication number
ATE533495T1
ATE533495T1 AT06716088T AT06716088T ATE533495T1 AT E533495 T1 ATE533495 T1 AT E533495T1 AT 06716088 T AT06716088 T AT 06716088T AT 06716088 T AT06716088 T AT 06716088T AT E533495 T1 ATE533495 T1 AT E533495T1
Authority
AT
Austria
Prior art keywords
serum proteins
exsudation
compositions
treatment
skin diseases
Prior art date
Application number
AT06716088T
Other languages
English (en)
Inventor
Seong-Hyun Choi
Original Assignee
Seong-Hyun Choi
Kt & G Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seong-Hyun Choi, Kt & G Corp filed Critical Seong-Hyun Choi
Application granted granted Critical
Publication of ATE533495T1 publication Critical patent/ATE533495T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A44—HABERDASHERY; JEWELLERY
    • A44C—PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
    • A44C15/00—Other forms of jewellery
    • A44C15/0045—Jewellery specially adapted to be worn on a specific part of the body not fully provided for in groups A44C1/00 - A44C9/00
    • A—HUMAN NECESSITIES
    • A44—HABERDASHERY; JEWELLERY
    • A44C—PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
    • A44C25/00—Miscellaneous fancy ware for personal wear, e.g. pendants, crosses, crucifixes, charms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06716088T 2005-02-28 2006-02-23 Zusammensetzungen zur behandlung von hautkrankheiten gekennzeichnet durch exsudation von serumproteinen ATE533495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050016567A KR100891595B1 (ko) 2005-02-28 2005-02-28 혈액 단백질의 삼출을 감소시키는 조성물
PCT/KR2006/000638 WO2006091033A1 (en) 2005-02-28 2006-02-23 Composition for reducing the exudation of serum proteins

Publications (1)

Publication Number Publication Date
ATE533495T1 true ATE533495T1 (de) 2011-12-15

Family

ID=36927638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06716088T ATE533495T1 (de) 2005-02-28 2006-02-23 Zusammensetzungen zur behandlung von hautkrankheiten gekennzeichnet durch exsudation von serumproteinen

Country Status (13)

Country Link
US (1) US8853195B2 (de)
EP (2) EP1855692B1 (de)
JP (2) JP5074929B2 (de)
KR (1) KR100891595B1 (de)
CN (1) CN101155589B (de)
AT (1) ATE533495T1 (de)
AU (1) AU2006217261B8 (de)
BR (1) BRPI0608367A2 (de)
CA (1) CA2599315C (de)
ES (1) ES2377137T3 (de)
PL (1) PL1855692T3 (de)
RU (1) RU2403047C2 (de)
WO (1) WO2006091033A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
CN101505763A (zh) * 2006-06-09 2009-08-12 鹿特丹伊拉斯姆斯大学医疗中心 通过肌醇磷脂调节免疫系统
KR101277630B1 (ko) * 2010-05-19 2013-06-21 주식회사 바이오피드 탈모방지 또는 육모 촉진용 조성물
KR101200392B1 (ko) * 2010-07-12 2012-11-13 주식회사 바이오피드 혈액 단백질 삼출을 동반하는 피부질환들의 치료 및 증상완화용 패치
CN103483425B (zh) * 2013-08-23 2015-03-18 南京中医药大学 一种具有致痒作用的芋蛋白提取物及其制备方法和应用
WO2019009628A2 (ko) * 2017-07-07 2019-01-10 주식회사 리포바이오랩 화상 및 욕창의 완화 및 치료용 조성물
RU2691648C1 (ru) * 2018-05-28 2019-06-17 Олег Александрович Розенберг Способ получения сурфактанта из легких крупного рогатого скота

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS624215A (ja) 1985-07-01 1987-01-10 Shiseido Co Ltd 化粧料
JPH07116010B2 (ja) * 1986-03-10 1995-12-13 株式会社コーセー 化粧料
JP3298867B2 (ja) 1988-06-20 2002-07-08 株式会社資生堂 透明組成物
AU660612B2 (en) * 1990-05-18 1995-07-06 Mitsubishi-Tokyo Pharmaceuticals, Inc. Remedy for asthma
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
WO1997005144A1 (fr) 1995-07-27 1997-02-13 Chisso Corporation Composes de silicium organique, composition de cristaux liquides, et element d'affichage a cristaux liquides
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
DE69732306T2 (de) 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
US20040228910A1 (en) * 1997-02-11 2004-11-18 Mse Pharmazeutika Gmbh Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
WO1998035658A2 (de) * 1997-02-12 1998-08-20 Mse Pharmazeutika Gmbh Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
JP3783385B2 (ja) 1997-08-26 2006-06-07 キユーピー株式会社 リポソーム分散液の製造方法及びそれを用いた化粧料
ATE229799T1 (de) * 1997-12-03 2003-01-15 Britannia Pharmaceuticals Ltd Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
US6320017B1 (en) * 1997-12-23 2001-11-20 Inex Pharmaceuticals Corp. Polyamide oligomers
US5989577A (en) 1998-03-02 1999-11-23 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
GB9912639D0 (en) * 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
WO2000030654A1 (en) 1998-11-26 2000-06-02 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
US7053176B1 (en) * 1999-09-16 2006-05-30 Altana Pharma Ag Combination of C1-INH and lung surfactant for the treatment of respiratory disorders
ES2525087T5 (es) * 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
HUP0301011A2 (hu) * 2000-09-01 2003-11-28 Johannes Jacobus Haitsma Dinamikus duzzadási viselkedésű tüdőfelület-aktív készítmények
RU2198670C1 (ru) 2002-02-19 2003-02-20 ООО "Биосурф" Способ получения сурфактанта из легких крупного рогатого скота
US20040009216A1 (en) 2002-04-05 2004-01-15 Rodrigueza Wendi V. Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
JP2004131401A (ja) * 2002-10-09 2004-04-30 Rohto Pharmaceut Co Ltd 皮膚化粧料
JP2004231544A (ja) 2003-01-29 2004-08-19 Nikko Chemical Co Ltd リン脂質のメラニン生成抑制剤としての利用
JP2004352643A (ja) 2003-05-29 2004-12-16 Kose Corp ゲル状化粧料
ES2383206T3 (es) * 2003-06-16 2012-06-19 Nycomed Gmbh Composición que comprende un tensioactivo pulmonar y sildenafilo para el tratamiento de neumopatías
TW200507879A (en) * 2003-07-10 2005-03-01 Kose Corp Powdery compositions and skin preparation containing the same for external use
CN1560057A (zh) * 2004-03-10 2005-01-05 山东师范大学 高纯度磷脂酰肌醇的制备方法
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물

Also Published As

Publication number Publication date
ES2377137T3 (es) 2012-03-22
HK1112592A1 (en) 2008-09-12
CN101155589A (zh) 2008-04-02
WO2006091033A1 (en) 2006-08-31
RU2007135881A (ru) 2009-04-10
AU2006217261B2 (en) 2009-10-01
CN101155589B (zh) 2011-06-15
BRPI0608367A2 (pt) 2009-12-29
AU2006217261B8 (en) 2010-01-28
US20090029950A1 (en) 2009-01-29
EP2295025A1 (de) 2011-03-16
US8853195B2 (en) 2014-10-07
PL1855692T3 (pl) 2012-05-31
CA2599315C (en) 2013-01-22
AU2006217261A1 (en) 2006-08-31
KR20060095141A (ko) 2006-08-31
EP1855692A4 (de) 2008-09-10
JP5074929B2 (ja) 2012-11-14
RU2403047C2 (ru) 2010-11-10
CA2599315A1 (en) 2006-08-31
EP1855692A1 (de) 2007-11-21
KR100891595B1 (ko) 2009-04-03
EP1855692B1 (de) 2011-11-16
JP2008531682A (ja) 2008-08-14
JP2012188434A (ja) 2012-10-04

Similar Documents

Publication Publication Date Title
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
SE0301010D0 (sv) Novel compounds
ATE405840T1 (de) Zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA200870380A1 (ru) Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
EA200870127A1 (ru) Полициклические производные аминокислот и способы их применения
BRPI0408388A (pt) compostos de benzopirano úteis no tratamento de patologias inflamatórias
EP1545587A4 (de) Lactoferrin-zusammensetzungen und wundbehandlungsverfahren
DE60235545D1 (de) Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen
EA200600588A1 (ru) Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз
ATE555116T1 (de) Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
EA201591180A1 (ru) Составы ингибитора lfa-1
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE533495T1 (de) Zusammensetzungen zur behandlung von hautkrankheiten gekennzeichnet durch exsudation von serumproteinen
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
DE602005027388D1 (de) Malonsäureamidderivate als inhibitoren von g-sekretase zur behandlung von alzheimer-krankheit
ATE512147T1 (de) Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer